Table 3

Muscimol binding and receptor expression at the cell surface

ReceptorKdBmaxEPMETC
nM %
αβ (WT)39  ± 5 (16)5.8  ± 0.2 (16)100100
α(L9′F)β52  ± 9 (6)6.9  ± 0.3 (6)3-a 109  ± 9 (5)98  ± 6 (5)
αβ(L9′F)92  ± 13 (8)3-a 6.2  ± 0.3 (8)84  ± 5 (5)101  ± 15 (5)
α(L9′F)β(L9′F)55  ± 6 (8)3-a 2.7  ± 0.3 (8)3-a 51  ± 5 (10)75  ± 6 (10)
α(L9′Y)β32  ± 5 (6)4.8  ± 0.2 (6)3-a 106  ± 17 (5)110  ± 8 (5)
αβ(L9′Y)49  ± 7 (6)4.6  ± 0.2 (6)3-a 83  ± 8 (5)105  ± 12 (5)
α(L9′Y)β(L9′Y)88  ± 14 (6)3-a 3.4  ± 0.2 (6)3-a 60  ± 2 (5)82  ± 7 (5)
αβ(L9′A)77, 965.6, 6.0
α(L9′A)β(L9′A)13, 236.0, 6.4

Muscimol binding parameters were calculated using eq. 2 for a single class of binding sites. Kd is the muscimol dissociation constant, and Bmax is maximal binding (pmol/106 cells). Values represent the mean ± S.E. forn ≥ 3. For detection of α1 in the plasma membrane and within the cell, Sf9 cells were labeled with the α1-specific monoclonal antibody, bd24, and the fluorescence of a FITC-conjugated secondary antibody was detected by flow cytometry. The level of plasma membrane (EPM) and the total cell (ETC) immunofluorescence is expressed as a percent of wild-type (αβ) immunofluorescence. The number of experiments carried out is shown in parentheses.

  • 3-a Values that are significantly different from wild type (WT), P ≤ .05.